Quality assurance of surgical gynecology in Hessen – Focus on gynecologic oncology

2001 ◽  
Vol 34 (2) ◽  
pp. 151-155
Author(s):  
A. du Bois
Keyword(s):  
Quality Assurance ◽  
Gynecologic Oncology ◽  
Surgical Gynecology

Influence of Department Volume on Survival for Ovarian Cancer: Results From a Prospective Quality Assurance Program of the Austrian Association for Gynecologic Oncology

2009 ◽  
Vol 19 (1) ◽  
pp. 94-102 ◽  
Author(s):  
Christian Marth ◽  
Sonja Hiebl ◽  
Willi Oberaigner ◽  
Raimund Winter ◽  
Sepp Leodolter ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Overall Survival ◽  
Quality Assurance ◽  
Residual Disease ◽  
Gynecologic Oncology ◽  
Quality Assurance Program ◽  
Birth Date ◽  
Mortality Data ◽  
Data Set ◽  
Department Volume

Objective:The Austrian Association for Gynecologic Oncology initiated in 1998 a prospective quality assurance program for patients with ovarian cancer. The aim of this study was to evaluate factors predicting overall survival especially under consideration of department volume.Methods:All Austrian gynecological departments were invited to participate in the quality assurance program. A questionnaire was sent out that included birth date, histology, date of diagnosis, stage, and basic information on primary treatment. Description of comorbidity was not requested. Patient life status was assessed in a passive way. We did record linkage between each patient's name and birth date and the official mortality data set collected by Statistics Austria. No data were available on progression-free survival. Patients treated between January 1, 1999 and December 31, 2004 were included in the analysis. Mortality dates were available to December 31, 2006. Data were analyzed by means of classical statistical methods. Cut-off point for departments was 24 patients per year.Results:A total of 1948 patients were evaluable. Approximately 75% of them were treated at institutions with fewer than 24 new patients per year. Patient characteristics were grossly similar for both department types. Multivariate analysis confirmed established prognostic factors such as International Federation of Gynecologists and Obstetricians (FIGO) stage, lymphadenectomy, age, grading, and residual disease. In addition, we found small departments (<24 patients per year) to have a negative effect on overall survival (hazards ratio, 1.38: 95% confidence interval, 1.2-1.7; and P < 0.001).Conclusions:The results indicate that in Austria, rules prescribing minimum department case load can further improve survival for patients with ovarian cancer.

Gynecologic Oncology Group quality assurance audits: analysis and initiatives for improvement

2010 ◽  
Vol 7 (4) ◽  
pp. 390-399 ◽  
Author(s):  
John A Blessing ◽  
Sally A Bialy ◽  
Charles W Whitney ◽  
Bette L Stonebraker ◽  
Frederick B Stehman
Keyword(s):  
Quality Assurance ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Oncology Group

Quality Assurance of Second Opinion Pathology in Gynecologic Oncology

1999 ◽  
Vol 94 (2) ◽  
pp. 302-306
Author(s):  
ALBERTO E. SELMAN ◽  
THEODORE H. NIEMANN ◽  
JEFFREY M. FOWLER ◽  
LARRY J. COPELAND
Keyword(s):  
Quality Assurance ◽  
Gynecologic Oncology ◽  
Second Opinion

The current state of quality assurance in surgical gynecology

2000 ◽  
Vol 33 (3) ◽  
pp. 206-212 ◽  
Author(s):  
M. Geraedts ◽  
C. Kugler
Keyword(s):  
Quality Assurance ◽  
Current State ◽  
Surgical Gynecology

Impact of a structured quality management program on survival of patients with advanced (AOC) and relapsed ovarian cancer (ROC) treated in a dedicated tertiary gynecologic-oncology (GO) center.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e17048-e17048
Author(s):  
Philipp Harter ◽  
Florian Heitz ◽  
Beyhan Ataseven ◽  
Sonia Prader ◽  
Stefanie Schneider ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Quality Assurance ◽  
Quality Management ◽  
Gynecologic Oncology ◽  
Management Program ◽  
Quality Assurance Program ◽  
Primary Therapy ◽  
Surgical Department ◽  
Number Of Patients ◽  
The Impact

e17048 Background: Treatment of AOC needs interdisciplinary and specialized skills and structures. We report the impact of a dedicated quality management program over 2 decades from learning curve and specialization process started in 1998-2004 when the surgical department was separated from a general clinic of obstetrics and gynecology. The next period from 2005-2010 covers the data after implementation of the first step of our ovarian cancer quality assurance program. In 2011, a dedicated department of GO was founded. Additionally, we investigated the role of subsequent centralized versus decentralized treatment when patients relapsed after they had primary therapy at our institution. Methods: Descriptive analysis of our prospective tumor registry including all consecutive patients with primary diagnosis of AOC FIGO IIB-IV treated from 1998-2004, 2005-2010 and 2011-2017. All patients having started any therapy outside of our center were excluded. Results: The number of patients with untreated AOC increased from 10 to 147 per year from 1998 to 2017. In total, 1,663 pts were analyzed. The annual percentage of FIGO IV increased from 14% in 1998 to 54-61% in recent years (2013-2017). The complete resection rate of upfront surgery was 50%, 67%, and 69% in the periods 1997-2004, 2005-2010, and 2011-2017, respectively. Correspondingly, median PFS increased from 19 to 21 and 26 months (p < 0.001) and median OS increased from 33 to 42 and 56 months, respectively (p < 0.001). Altogether, 893 pts (53.7%) experienced a relapse. 490/893 pts (54.9% of all ROC pts) were treated again in our center, the remaining 45.1% were treated somewhere else. Median OS calculated from first relapse was 43 months for patients re-treated in our institution versus 32 months for others (p < 0.001). Conclusions: We demonstrate a correlation between specialization and improved outcome in AOC. Focusing and implementing a quality assurance program including structural evolution from a department of general obstetrics/gynecology to a department of GO led to an improvement although systemic primary treatment standards did not change during this period.

Sign in / Sign up

Export Citation Format

Share Document